Screener
QuidelOrtho Corporation QDEL Royalty and License Expenses
Royalty and License Expenses at other companies
Other financials
Where this comes from
Reported directly by QuidelOrtho Corporation in its filing.
Tagged under the XBRL concept qdel:RoyaltyAndLicenseExpenses.
The source filing: QuidelOrtho Corporation’s 10-K, filed February 19, 2026.
- Filed
- Feb 18, 2026, 9:45 PM EST
- Fiscal year
- FY2025
- Accession
- 0001906324-26-000008
The Company has entered into various licensing and royalty agreements, which largely require payments by the Company based on specified product sales, as well as the achievement of specified milestones. The Company had royalty and license expenses relating to those agreements of approximately $14.0 million, $18.5 million and $21.8 million for fiscal years ended 2025, 2024 and 2023, respectively.
Item 8. Financial Statements and Supplementary Data
FAQ
- What is QuidelOrtho Corporation's royalty and license expenses?
- QuidelOrtho Corporation (QDEL) reported royalty and license expenses of $3.5M in Q4 2025.
- How has QuidelOrtho Corporation's royalty and license expenses changed year-over-year?
- QuidelOrtho Corporation's royalty and license expenses decreased by 24.3% year-over-year, from $4.63M to $3.5M.
- What is the long-term trend for QuidelOrtho Corporation's royalty and license expenses?
- Over 2 years (2023 to 2025), QuidelOrtho Corporation's royalty and license expenses has grown at a -19.9% compound annual growth rate (CAGR), from $21.8M to $14M.
- What does royalty and license expenses mean?
- Costs incurred for the use of intellectual property, patents, or proprietary technologies owned by third parties. These expenses reflect the company's reliance on external innovation and the ongoing operational costs required to maintain access to critical diagnostic or manufacturing technologies.
Ask your AI about QuidelOrtho Corporation's royalty and license expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude